BioNTech

Biotechnology
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

$24.7B

Market Cap • 11/26/2025

2008

(17 years)

Founded

2019

(6 years ago)

IPO

NASDAQ

Listing Exchange

Flag of Germany

Germany

Country